Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis

Decorative image of the AMR Learning Lounge

Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis

SUMMARY

Frequent use of antibiotics in patients with COVID-19 has the potential to worsen antimicrobial resistance. A systematic review of 148 studies of 362,976 laboratory-confirmed COVID-19 patients found that among those with bacterial co-infections, the proportion of infections resistant to antimicrobials was 60.8%. Emerging evidence suggests that surges in COVID-19-related hospital admissions are associated with an increase in antibiotic-resistant infections.

FEATURED EXPERT

Bradley J. Langford, PharmD, Pharmacist Specialist, Antimicrobial Stewardship Program, Public Health Ontario, Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada

Miranda So, PharmD, MPH, Program Lead & Research Director, SH-UHN Antimicrobial Stewardship Program, Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada

GET STARTED

Read the complete article at The Lancet Microbe.

Take me there now!

Read time: 30 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

GLOBAL Solutions

Antimicrobial Stewardship Solutions

Antimicrobial Resistance is undermining modern medicine and putting patients at risk of premature death. bioMérieux is committed to preserving antibiotic efficacy with the right diagnostic tests that guide appropriate and responsible use of antibiotics to ensure they remain lifesaving for posterity.

Learn More

US Solution

Antimicrobial Stewardship

With its advanced immunoassay technology and optimized testing protocols, the fully automated VIDAS® 3 benchtop immunoanalyzer empowers your lab with confidence, offering the precise results you need, when you need them.

Learn More